The
Center for Clinical Precision Medicine and Genomics (CCPMG) at Hamad Medical Corporation (HMC) is at the forefront of transforming healthcare in Qatar and beyond. CCPMG is aligned with Qatar’s
National Vision 2030 and the
Qatar National Development Strategy 2024–2030 and is committed to positioning Qatar as a global leader in precision medicine.
Precision medicine is an innovative approach that uses an individual’s genomic, environmental, and lifestyle information to guide medical decisions. By placing patients at the center of care, precision medicine delivers targeted and effective care.
The
Precision Medicine (PM) vision was introduced to Qatar by
H.H. Sheikha Moza Bent Nasser, who spearheaded the establishment of the
Qatar Precision Health Institute, a national center for research and implementation under Qatar Foundation. Its primary focus is to enhance precision healthcare quality and value through comprehensive study of genomics and multi-omics which lead to creating large-scale genomic databases. These efforts aim to empower implementation of personalized healthcare into Qatar’s national healthcare system.
To promote precision medicine at HMC,
Dr. Abdulla Al Ansari, Chief Medical Officer of HMC, established the
HMC Precision Medicine Committee, with Dr. Salha Bujassoum Al-Bader as Assistant Chair. Representing all key clinical areas across HMC, this committee provides oversight, advises on clinical applications of precision medicine, and ensures that its implementation aligns with evidence-based practices.
Advancing Precision Medicine at HMC
The Center for Clinical Precision Medicine and Genomics aims to create a
Center of Excellence in clinical precision medicine. Our mission includes:
-
Accelerating the clinical implementation of precision medicine to transform patient care.
-
Adopting new technologies to advance diagnostic and therapeutic capabilities.
-
Promoting digital health to ensure accessible, equitable healthcare for all.
-
Establishing partnerships and collaborations at national and international levels to drive innovation and foster knowledge exchange.
Driving Innovation and Excellence
HMC initiatives in pharmacogenomics, artificial intelligence, and genomic research have positioned HMC as a global leader in healthcare innovation. The
HMC Precision Medicine Conference, which was held three times, serves as a key platform for knowledge exchange, fostering collaborations and addressing challenges in the field.
Commitment to Qatar’s Vision
Guided by Qatar’s National Vision 2030 and the Qatar National Development Strategy 2024–2030, the Center embodies the nation’s commitment to excellence, sustainability, and innovation in healthcare. By transforming precision medicine from a promise into an everyday reality, we aim to enhance patient outcomes and improve the quality of life and access to care for all.
